Panakeia
About Panakeia
Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer.
Our AI-powered PANProfiler platform delivers fast, accurate molecular insights directly from routine pathology slides, helping clinicians make same-day treatment decisions and easing pressure on overstretched labs. Products are already deployed in NHS hospitals, enabling a more responsive, precise cancer care pathway for everyone.
Founded in 2018 and headquartered in London, England, Panakeia operates in the software development industry with a team of 11-50 employees. The company specializes in Machine Learning, Deep Learning, Artificial Intelligence, Cancer Diagnostics, and Personalized Medicine.
Location
30 Aldwych, London, England, GB
Mission & Vision
Panakeia's mission is to accelerate molecular insights and ensure timely, precise cancer care is a reality for everyone through cutting-edge AI-driven diagnostics, particularly focused on cancer.